Predictive Factors for Central Line-Associated Bloodstream Infections in Pediatric Cardiac Surgery Patients With

Stephanie G Waterhouse1, Jeffrey E Vergales2, Mark R Conaway3

  • 1Department of Pediatric Critical Care, Vanderbilt University Medical Center, Nashville, TN.

Insights

Pediatric cardiac surgery patients with chylothorax have a higher risk of central line-associated bloodstream infections. Key risk factors include surgical complexity, longer catheter use, and chest tube output, aiding targeted prevention.

Area of Science:

  • Pediatric critical care medicine
  • Infectious disease epidemiology
  • Cardiovascular surgery outcomes

Background:

  • Central line-associated bloodstream infections (CLABSIs) are a significant concern in pediatric intensive care units (PICUs).
  • Chylothorax, a complication following cardiac surgery, may increase the risk of CLABSIs in this vulnerable population.
  • Identifying specific risk factors is crucial for effective prevention strategies.

Purpose of the Study:

  • To determine the prevalence of CLABSIs in pediatric cardiac surgery patients with and without chylothorax.
  • To identify risk factors associated with CLABSIs in pediatric patients with chylothorax post-cardiac surgery.
  • To inform targeted interventions for high-risk individuals.

Main Methods:

  • Retrospective single-center cohort study.
  • Inclusion of all pediatric patients undergoing cardiac surgery and admitted to the PICU from 2008 to 2014.
  • Analysis of patient data including chylothorax status, CLABSI occurrence, surgical complexity (Risk Adjustment Congenital Heart Surgery score), central venous catheter duration, and chest tube output.

Main Results:

  • A total of 1,191 patients were analyzed; 66 (5.5%) had chylothorax.
  • Patients with chylothorax had a significantly higher incidence of CLABSI (23% vs. 3.8%, p < 0.001).
  • In patients with chylothorax, higher Risk Adjustment Congenital Heart Surgery score, longer central venous catheter duration, and increased 24-hour chest tube output predicted higher CLABSI risk.

Conclusions:

  • The prevalence of CLABSI is elevated in pediatric cardiac surgery patients with chylothorax.
  • Surgical complexity, prolonged central venous catheterization, and significant chest tube drainage are key predictors of CLABSI in this cohort.
  • These findings enable the identification of high-risk patients for focused CLABSI prevention efforts.
Abstract

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
266
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
320
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
239
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.7K
Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
332
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
305